The open-access bioinformatics tool EnzymeMiner 2.0, developed at the Loschmidt Laboratories, scans extensive databases of natural enzymes. Based on specified parameters, it identifies those with the desired properties for industry, medicine, or environmental protection.
"Instead of spending years genetically modifying an enzyme in the lab, you can now ask if something better already exists in nature," says the article's lead author, PhD candidate Monika Rosinská. "Most proteins in public databases have never been studied. Nature may already contain the enzymes that industry needs. Finding these valuable enzymes among a billion sequences is difficult. And that is precisely what EnzymeMiner does," Rosinská explains.
EnzymeMiner 2.0 is free and runs online in a standard browser. The user simply pastes a known enzyme and specifies the functional requirements for the new target enzyme. For example, better stability or resistance to high industrial temperatures. Within a few hours, the system searches the databases, automatically filtering and ranking the most similar and suitable candidates.
In addition to larger databases and automated filtering, version 2.0 introduces several upgrades over the original variant. For instance, the server can now predict the properties and behaviour of an enzyme prior to laboratory testing.
Researchers from the Loschmidt Laboratories at the RECETOX Centre collaborated on the development alongside colleagues from the Faculty of Science at Masaryk University, the International Clinical Research Centre (ICRC) at St. Anne's University Hospital, and the Faculty of Information Technology at Brno University of Technology.
The study was supported by the EU Horizon 2020 program (grant agreement no. 857560 – CETOCOEN Excellence) and the Horizon Europe Framework (no. 101136607 – CLARA). Support was also provided by the Czech Science Foundation (no. 25-18233M). Monika Rosinská was supported by the Brno Ph.D. Talent scholarship, funded by the Statutory City of Brno. Computational resources were provided by e-INFRA CZ, ELIXIR-CZ, and RECETOX RI projects (90254, LM2023055, LM2023069), with support from MŠMT.
DOI: https://doi.org/10.1093/nar/gkag424